Smith A - Search Results

1

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.

Aminkeng F, Ross CJ, Rassekh SR, Hwang S, Rieder MJ, Bhavsar AP, Smith A, Sanatani S, Gelmon KA, Bernstein D, Hayden MR, Amstutz U, Carleton BC; CPNDS Clinical Practice Recommendations Group. Aminkeng F, et al. Among authors: smith a. Br J Clin Pharmacol. 2016 Sep;82(3):683-95. doi: 10.1111/bcp.13008. Epub 2016 Jun 30. Br J Clin Pharmacol. 2016. PMID: 27197003 Free PMC article. Review.

2

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.

Ross CJ, Katzov-Eckert H, Dubé MP, Brooks B, Rassekh SR, Barhdadi A, Feroz-Zada Y, Visscher H, Brown AM, Rieder MJ, Rogers PC, Phillips MS, Carleton BC, Hayden MR; CPNDS Consortium. Ross CJ, et al. Nat Genet. 2009 Dec;41(12):1345-9. doi: 10.1038/ng.478. Epub 2009 Nov 8. Nat Genet. 2009. PMID: 19898482

3

The added burden of comorbidity in patients with asthma.

Zhang T, Carleton BC, Prosser RJ, Smith AM. Zhang T, et al. J Asthma. 2009 Dec;46(10):1021-6. doi: 10.3109/02770900903350473. J Asthma. 2009. PMID: 19995140

4

The comorbidity burden of the treated asthma patient population in British Columbia.

Prosser R, Carleton B, Smith A. Prosser R, et al. Among authors: smith a. Chronic Dis Can. 2010 Mar;30(2):46-55. Chronic Dis Can. 2010. PMID: 20302685 Free article.

5

Fifty years of pediatric asthma in developed countries: how reliable are the basic data sources?

Chawla J, Seear M, Zhang T, Smith A, Carleton B. Chawla J, et al. Among authors: smith a. Pediatr Pulmonol. 2012 Mar;47(3):211-9. doi: 10.1002/ppul.21537. Epub 2011 Sep 8. Pediatr Pulmonol. 2012. PMID: 21905263

6

Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.

Aminkeng F, Ross CJ, Rassekh SR, Brunham LR, Sistonen J, Dube MP, Ibrahim M, Nyambo TB, Omar SA, Froment A, Bodo JM, Tishkoff S, Carleton BC, Hayden MR; Canadian Pharmacogenomics Network for Drug Safety Consortium. Aminkeng F, et al. Pharmacogenomics J. 2014 Apr;14(2):160-70. doi: 10.1038/tpj.2013.13. Epub 2013 Apr 16. Pharmacogenomics J. 2014. PMID: 23588107 Free PMC article.

7

Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.

Pussegoda K, Ross CJ, Visscher H, Yazdanpanah M, Brooks B, Rassekh SR, Zada YF, Dubé MP, Carleton BC, Hayden MR; CPNDS Consortium. Pussegoda K, et al. Clin Pharmacol Ther. 2013 Aug;94(2):243-51. doi: 10.1038/clpt.2013.80. Epub 2013 Apr 10. Clin Pharmacol Ther. 2013. PMID: 23588304 Free PMC article.

8

HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.

Amstutz U, Ross CJ, Castro-Pastrana LI, Rieder MJ, Shear NH, Hayden MR, Carleton BC; CPNDS Consortium. Amstutz U, et al. Clin Pharmacol Ther. 2013 Jul;94(1):142-9. doi: 10.1038/clpt.2013.55. Epub 2013 Mar 18. Clin Pharmacol Ther. 2013. PMID: 23588310 Free PMC article.

9

Hair cortisol as a novel biomarker of HPA suppression by inhaled corticosteroids in children.

Smy L, Shaw K, Smith A, Russell E, Van Uum S, Rieder M, Carleton B, Koren G. Smy L, et al. Among authors: smith a. Pediatr Res. 2015 Jul;78(1):44-7. doi: 10.1038/pr.2015.60. Epub 2015 Mar 19. Pediatr Res. 2015. PMID: 25790275

10

New Ways of Detecting ADRs in Neonates and Children.

Jimenez R, Smith A, Carleton B. Jimenez R, et al. Among authors: smith a. Curr Pharm Des. 2015;21(39):5643-9. doi: 10.2174/1381612821666150901105555. Curr Pharm Des. 2015. PMID: 26323415 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,912 results

Search Page